Evotec SE has received a $18 million grant from the Bill & Melinda Gates Foundation for the integrated discovery and development of a novel, first-in-class program to accelerate progress in the area of women’s health and contraceptive technology, leveraging Evotec’s integrated R&D platform.   The project makes use of Evotec’s fully-integrated drug discovery and development platforms as well as therapeutic area expertise to take an idea from concept to nomination of a ...